Loading...
51 Diabetes Care Drugs Reports
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Latin America, Asia Pacific
Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia Pacific, South America
Major Players: Vivus, F Hoffmann-La Roche AG, GlaxoSmithKline PLC, Novo Nordisk AS, Currax Pharmaceuticals LLC
Study Period: 2019 - 2029
Country Covered: New Zealand
Major Players: Astellas Pharma Inc., AstraZeneca, Sanofi, Eli Lilly and Company, Janssen Pharmaceuticals
Study Period: 2018 - 2029
Countries Covered: Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, Thailand, Vietnam
Major Players: Astrazeneca, Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company, Sanofi Aventis
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Convatec Inc., 3M, Integra LifeSciences, Coloplast Corp, Cardinal Health
Study Period: 2019 - 2029
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Novartis AG, Regeneron Pharmaceuticals Inc, Allergan Plc, Hoffmann-La Roche (Genentech), Oxurion NV
Study Period: 2019- 2029
Regions Covered: North America, Europe, Latin America, Asia Pacific, Middle East and Africa
Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S
Study Period: 2018 - 2029
Country Covered: Japan
Major Players: Takeda, AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Study Period: 2019 - 2029
Country Covered: Indonesia
Major Players: Eli Lilly, Boehringer Ingelheim, Sanofi, Novo Nordisk, AstraZeneca
Study Period: 2018 - 2029
Country Covered: Brazil
Major Players: AstraZeneca, MSD, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Study Period: 2018 - 2029
Country Covered: Russia
Major Players: AstraZeneca, Eli Lilly, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Study Period: 2018 - 2029
Country Covered: Oman
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Study Period: 2018 - 2029
Country Covered: Germany
Major Players: Novo Nordisk A/S, Sanofi Aventis, AstraZeneca, Eli Lilly and Company, Merck
Study Period: 2018 - 2029
Country Covered: Italy
Major Players: Novo Nordisk A/S, AstraZeneca, Boehringer Ingelheim, Sanofi Aventis, Eli Lilly and Company
Study Period: 2018 - 2029
Country Covered: United Kingdom
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Study Period: 2018 - 2029
Country Covered: France
Major Players: AstraZeneca, Boehringer Ingelheim, Sanofi Aventis, Novo Nordisk A/S, Eli Lilly and Company
Study Period: 2018 - 2029
Country Covered: South Africa
Major Players: AstraZeneca, Merck, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Study Period: 2021- 2029
Country Covered: South Korea
Major Players: AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A/S, Sanofi Aventis
Study Period: 2018 - 2029
Country Covered: Mexico
Major Players: AstraZeneca, Novo Nordisk, Boehringer Ingelheim, Eli Lilly and Company, Sanofi Aventis
Study Period: 2018 - 2029
Country Covered: Saudi Arabia
Major Players: AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S, Sanofi Aventis
Study Period: 2018 - 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Boehringer Ingelheim, Astrazeneca, Eli Lilly, Sanofi, Novo Nordisk
Study Period: 2018 - 2029
Countries Covered: United Kingdom, Germany, France, Russia, Spain, Italy
Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Biocon
Study Period: 2019- 2029
Countries Covered: United States, Canada
Major Players: Novo Nordisk, Abbott, Sanofi, Eli Lilly, Merck
Study Period: 2019 - 2029
Countries Covered: Brazil, Mexico
Major Players: Novo Nordisk, Sanofi, Eli Lilly, AstraZeneca, Boehringer Ingelheim
Study Period: 2019 - 2029
Country Covered: Egypt
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Study Period: 2018 - 2029
Regions Covered: North America, Europe, Latin America, Asia-Pacific, Middle East and Africa
Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca
Study Period: 2019 - 2029
Countries Covered: China, Japan, India, Australia, South Korea
Major Players: Sanofi, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., AstraZeneca
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico
Major Players: Sanofi, Novo Nordisk A/S, AstraZeneca, Pfizer Inc., Novartis AG
Study Period: 2019 - 2029
Country Covered: Japan
Major Players: Sanofi, Eli Lilly and Company, Pfizer Inc., AstraZeneca, Johnson And Johnson
Study Period: 2018 - 2029
Country Covered: China
Major Players: Eli Lilly, Boehringer Ingelheim, Astrazeneca, Sanofi, Novo Nordisk
Filter Reports
By Region
By Countries
